These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29543105)

  • 1. Regioselectivity significantly impacts microsomal glucuronidation efficiency of R/S-6, 7-, and 8-hydroxywarfarin.
    Kim SY; Jones DR; Kang JY; Yun CH; Miller GP
    Xenobiotica; 2019 Apr; 49(4):397-403. PubMed ID: 29543105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases.
    Zielinska A; Lichti CF; Bratton S; Mitchell NC; Gallus-Zawada A; Le VH; Finel M; Miller GP; Radominska-Pandya A; Moran JH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):139-48. PubMed ID: 17921187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.
    Bratton SM; Mosher CM; Khallouki F; Finel M; Court MH; Moran JH; Radominska-Pandya A
    J Pharmacol Exp Ther; 2012 Jan; 340(1):46-55. PubMed ID: 21972237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites.
    Pugh CP; Pouncey DL; Hartman JH; Nshimiyimana R; Desrochers LP; Goodwin TE; Boysen G; Miller GP
    Arch Biochem Biophys; 2014 Dec; 564():244-53. PubMed ID: 25447818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.
    Jones DR; Kim SY; Guderyon M; Yun CH; Moran JH; Miller GP
    Chem Res Toxicol; 2010 May; 23(5):939-45. PubMed ID: 20429590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarins.
    Kim SY; Kang JY; Hartman JH; Park SH; Jones DR; Yun CH; Boysen G; Miller GP
    Drug Metab Lett; 2012 Sep; 6(3):157-64. PubMed ID: 23331088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin.
    Miller GP; Lichti CF; Zielinska AK; Mazur A; Bratton SM; Gallus-Zawada A; Finel M; Moran JH; Radominska-Pandya A
    Drug Metab Dispos; 2008 Nov; 36(11):2211-8. PubMed ID: 18725508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
    Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
    Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism.
    Jones DR; Moran JH; Miller GP
    Drug Metab Rev; 2010 Feb; 42(1):55-61. PubMed ID: 19788348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitor.
    Omura K; Nakazawa T; Sato T; Iwanaga T; Nagata O
    Drug Metab Dispos; 2007 Dec; 35(12):2143-8. PubMed ID: 17761779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases.
    Ruan JQ; Yan R
    Chem Biol Interact; 2014 Sep; 220():231-40. PubMed ID: 25044472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
    Tachibana M; Tanaka M; Masubuchi Y; Horie T
    Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.
    Court MH; Duan SX; von Moltke LL; Greenblatt DJ; Patten CJ; Miners JO; Mackenzie PI
    J Pharmacol Exp Ther; 2001 Dec; 299(3):998-1006. PubMed ID: 11714888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
    Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
    Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
    Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
    Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of bergenin.
    Song H; Wang J; Zhang R; Liu X; Yuan G; Wei C; Wang B; Guo R
    Biomed Chromatogr; 2014 Mar; 28(3):348-53. PubMed ID: 23996546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
    Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.